Real-time enrollment status for this amyotrophic lateral sclerosis clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 1:58 AM UTC
| NCT Number | NCT05407324 |
| Recruiting Status | Recruiting |
| Condition | Amyotrophic Lateral Sclerosis |
| Phase | PHASE2 |
| Target Enrollment | 279 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Corcept Therapeutics |
| Last Updated on CT.gov | June 16, 2026 (Jun 16, 2026) |
As of September 2, 2026: Clinical trial NCT05407324 is currently recruiting participants. This phase2 study for amyotrophic lateral sclerosis is actively seeking new participants at 4 locations across the United States. The study is sponsored by Corcept Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05407324 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05407324 was last updated Jun 16, 2026 (June 16, 2026). HelloStudys verifies this status automatically.